±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 5406  |  »Ø¸´: 28
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

1127love

Í­³æ (³õÈëÎÄ̳)

[½»Á÷] PhD positions in LMU, Munich, Germany ÒÑÓÐ18È˲ÎÓë

Ñо¿×鼯»®ÕÐÆ¸PhDѧÉú £¨ÏêÇéÇë¼ûÏÂÃæµÄ¹ã¸æ£©£¬²©Ê¿ÆÚ¼ä¹¤×ÊÓÉDFGÏîÄ¿Ìṩ£¬ÊÕÈë°´Õյ¹úTVL-13µÈ¼¶ (50% - 65%), ˰ºó£¨Òѿ۳ý¹«Á¢Ò½ÁƱ£ÏÕ·ÑÓã©´ó¸ÅÓÐ1200 - 1500 ŷÿ¸öÔ £¨µÂ¹ú˰ºó¹¤×ʸú¸öÈ˵Ť×÷ÄêÏÞ£¬»éÒö״̬£¬ÓÐûÓÐСº¢ÓÐÖ±½Ó¹ØÏµ£©¡£µÂ¹úĽÄáºÚ´óѧע²á£¬±ÏÒµÖ®ºóÄõÄÊÇĽÄáºÚ´óѧµÄѧλ¡£

ÎÒÃÇÑо¿ËùÖ÷ÒªÊÇ´Óʶ¯ÂöÖàÑùÓ²»¯»úÀíÑо¿£¬ÒÔ¶¯ÎïÄ£ÐÍΪÖ÷¡£ÏêÇéÇë¼ûËùÀïÖ÷Ò³http://www.klinikum.uni-muenchen ... 0-People/index.html¡£ÏÖÔÚÓв»Í¬µÄÑо¿Ð¡×飬´Óʲ»Í¬·½ÏòµÄÑо¿¡£ÎÒÃÇÑо¿Ð¡×éÔÚProf. Andreas HabenichtµÄ´øÁìÏ£¬Ö÷ÒªÒÔ78ÖܵÄApoE-/-СÊóΪģÐÍ£¬Ñо¿Ñª¹ÜÍâĤµÄadaptive immune responses¡£Prof. HabenichtÔÚ2004 ¨C 2005ÄêÖ®¼ä·¢ÏÖ¶¯ÂöÖàÑùÓ²»¯Ñª¹ÜÍâĤ³öÏÖTϸ°ûºÍBϸ°û¾Û¼¯£¬Õâ¸öз¢ÏֵĽṹ±»Prof. HabenichtÃüÃûΪArtery Tertiary Lymphoid Organ£¨ATLO£©, ¾­¹ý½ü10ÄêµÄÑо¿·¢ÏÖ£¬ATLOs¿ÉÄÜ¿ØÖÆÁ˶¯ÂöÖàÑùµÄÃâÒß·´Ó¦£¬²¢¾ßÓж¯ÂöÖàÑùÓ²»¯±£»¤×÷Óã¨ÏêÇé¿É²Î¿¼ÎÄÏ×Zhao L et al., 2004, Nat Med; Moos MP et al., 2005, ATVB; Gräbner R et al., 2009, JEM; Mohanta SK and Yin C et al., 2014, Cir Res; Hu D et al., 2015, Immunity£©¡£ ¹ØÓÚProf. Andreas Habenicht£¬¿É²Î¼ûÆä·¢±íµÄÎÄÏ×http://www.ncbi.nlm.nih.gov/pubmed/?term=Habenicht+A%5BAuthor%5D¡£

¹ØÓÚÓ¢ÓïµÄÒªÇó£¬ÎÒÃDz¢²»Ç¿ÖÆÒªÇóÑÅ˼»òÕ߯äËûµÄ³É¼¨Ö¤Ã÷¡£µ«ÊDz¢²»ÊÇ˵ÎÒÃǶÔÓïÑÔûÓÐÒªÇó£¬ÎÒÃÇÆÚ´ý3¸öÔÂÖ®ºó£¬ÄãÄܹ»ÓÃÓ¢ÓïͬÆäËûµÄͬÊÂÕý³£½»Á÷£¬6¸öÔÂÖ®ºóÄܹ»ÓÃÓ¢ÓïÔÚËùÀï×öѧÊõ±¨¸æ¡£ÁíÍ⣬ÌáÐÑ´ó¼ÒÒ»¸öÏà¹ØµÄ·çÏÕÊÇ£¬¸ù¾ÝµÂ¹úµÄ·¨ÂÉ£¬Ò»°ãÒ»¿ªÊ¼¶¼ÊǸø6¸öԵŤ×÷ºÏͬ£¬¹ÍÖ÷ÊÇÓÐȨÀûÔÚ6¸öÔÂÖ®ºóÖÕÖ¹ºÏͬµÄ¡£

»¶Ó­¶Ô¿ÆÑзdz£¸ÐÐËȤµÄͬѧÇë·¢ËÍ CV + motivation letter + contact details of 2 referees µ½ Dr. Sarajo Mohanta (sarajo.mohanta@med.uni-muenchen.de) or Dr. Changjun Yin (changjun.yin@med.uni-muenchen.de). £¨Ö®Ç°ÓÐЩͬѧ»¹È±ÁËÄÄЩÎļþ¸Ï½ô²¹·¢Ò»Ï°ɣ¡£©

ÆäÖÐÒ»¸öְλÖ÷Òª´ÓÊÂnext-generation sequencing·½ÃæµÄ¹¤×÷£¬Ìرð»¶Ó­ÓÐNGSÎÄ¿âÖÆ±¸£¬Êý¾Ý·ÖÎöµÈ¹¤×÷¾­ÑéµÄͬѧ¡£
ÁíÍâÒ»¸öְλÖ÷Òª´Óʶ¯ÂöÖàÑùÓ²»¯ºÍÉñ¾­ÏµÍ³crosstalk¡£
һЩ¾ßÌåµÄÒªÇóÇë×¢Òâ¿´ÏÂÃæµÄÓ¢ÎÄ¹ã¸æ¡£

PhD positions for projects in basic cardiovascular research funded by the German Research Council.

We are recruiting PhD candidates at the Institute for Cardiovascular Prevention (IPEK) in Munich (http://www.klinikum.uni-muenchen ... search/index.html). PhD students will work in an international team of experienced staff, PhD students, and postdocs. Salary according to TV-L (duration 3 years). Interview expenses will not be reimbursed.
Research areas:
Cardiovascular research in atherosclerosis T/B cell autoimmunity and atherosclerosis-nervous system crosstalk in aged hyperlipidemic mice.
Techniques:
Flow cytometry, confocal laser scanning microscopy, next-generation sequencing, software application, mouse dissection, microsurgery, and cell culture.
Requirements:
Immunology, cell biology, molecular biology and microscopy. Interest in cardiovascular diseases, fluent English, teamwork, commitment, resilience, and desire to learn new techniques.
Contact:
Please send your application, including CV, motivation letter, and contact details of 2 referees to Dr. Sarajo Mohanta (sarajo.mohanta@med.uni-muenchen.de) or Dr. Changjun Yin (changjun.yin@med.uni-muenchen.de).
Suggested Readings:
1. Gräbner et al. 2009. Journal of Experimental Medicine 206, 233-248.
2. Hu and Mohanta et al. 2015. Immunity 42, 1100-1115.
Address:
Andreas Habenicht, M.D.; Professor of Medicine; Institute for Cardiovascular Disease Prevention (IPEK); Ludwig-Maximilians-University (LMU) Munich Pettenkoferstr. 9; 80336 Munich, Germany

±¾ÕÐÆ¸ÐÅÏ¢À´Ô´£ºhttp://www.klinikum.uni-muenchen ... toranden/index.html

[ Last edited by 1127love on 2016-3-22 at 21:56 ]
»Ø¸´´ËÂ¥

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1127love

Í­³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
8Â¥: Originally posted by wqyjiu at 2016-03-22 00:18:10
Õâ¸öÓ¢ÓïÊÇ×Ô¼ºÑ§Ï°£¬»¹ÊÇÓÐÅàѵµÄ»ú»á£¿

×Ô¼ºÑ§Ï°£¬Èç¹ûÄã¾õµÃ×Ô¼ºÑ§µÃÂý£¬Ò²¿ÉÒÔ×Ô¼ºÕÒµ±µØµÄÅàѵ»ú¹¹ £¨Ò»°ãÊÇ·ÑÓôÓ×Ô¼º¹¤×ÊÀïÃæ³ö£©¡£
10Â¥2016-03-22 16:35:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 29 ¸ö»Ø´ð

wavehy

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ûдÐèÒªÄÄЩרҵµÄѧÉúÂð£¿
2Â¥2016-03-21 19:59:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1127love

Í­³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by wavehy at 2016-03-21 19:59:43
ûдÐèÒªÄÄЩרҵµÄѧÉúÂð£¿

ÉúÎï»òÕßҽѧÏà¹ØµÄ¶¼¿ÉÒԵġ£
3Â¥2016-03-21 20:27:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

shenbaihua

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Äܱ¾¿ÆÖ±ÉêÂð£¿ÓйýÒ»ÄêÔÚÃÀ¹ú¿ÆÑÐʵϰµÄ¾­Àú

·¢×ÔСľ³æIOS¿Í»§¶Ë
4Â¥2016-03-21 21:06:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 266Çóµ÷¼Á +7 ÑôÑôÍÛÈû 2026-03-27 8/400 2026-03-27 13:04 by zzll406
[¿¼ÑÐ] 269ר˶Çóµ÷¼Á +9 ½ð¶÷±´ 2026-03-21 9/450 2026-03-27 11:25 by ÍõЦÓîÒ»¶¨ÊÇÑо
[¿¼ÑÐ] µ÷¼ÁÍÆ¼ö +5 Ç徯714 2026-03-26 6/300 2026-03-27 11:12 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á +5 .m.. 2026-03-25 5/250 2026-03-27 11:08 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 0703»¯Ñ§Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ303Çóµ÷¼Á +3 zzffylgg 2026-03-24 3/150 2026-03-27 10:42 by shangxh
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤·½Ïò336·Ö +3 ³½ãå5211314 2026-03-26 3/150 2026-03-27 10:24 by ¾¡Ë´Ò¢1
[˶²©¼ÒÔ°] ±±¾©ÁÖÒµ´óѧ˶µ¼ÕÐÉú¹ã¸æ +6 kongweilin 2026-03-26 8/400 2026-03-27 10:18 by FF_16
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-27 3/150 2026-03-27 10:17 by guoweigw
[¿¼ÑÐ] 304²ÄÁÏÇóµ÷¼Á +4 ÖÓllll 2026-03-26 4/200 2026-03-27 03:42 by wxiongid
[¿¼ÑÐ] ²ÄÁϵ÷¼Á 5+4 ÏëÒªÒ»ºøÌÒ»¨Ë® 2026-03-25 10/500 2026-03-26 19:56 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸211 ³õÊÔ270·Ö Çóµ÷¼Á +6 ¹ÈÓêÉϰ¶ 2026-03-23 7/350 2026-03-26 18:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +9 µ¾ÆÞС±à 2026-03-26 9/450 2026-03-26 16:16 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 0856Çóµ÷¼Á +8 zhn03 2026-03-25 9/450 2026-03-26 13:42 by zzll406
[¿¼ÑÐ] ѰÕÒµ÷¼Á +5 ¾óǿâ? 2026-03-21 8/400 2026-03-26 13:25 by 0906ljy
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯315 Çóµ÷¼Á +3 akrrain 2026-03-24 3/150 2026-03-24 19:35 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] 306Çó0703µ÷¼ÁÒ»Ö¾Ô¸»ªÖÐʦ·¶ +10 Ö½Óãly 2026-03-21 11/550 2026-03-24 17:22 by qingfeng258
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ0817»¯¹¤278·ÖÇóµ÷¼Á +7 jhybd 2026-03-23 12/600 2026-03-24 09:03 by jhybd
[¿¼ÑÐ] 298Çóµ÷¼ÁÒ»Ö¾Ô¸211 +3 Éϰ¶6666@ 2026-03-20 3/150 2026-03-22 15:50 by ColorlessPI
[¿¼ÑÐ] 336Çóµ÷¼Á +5 rmc8866 2026-03-21 5/250 2026-03-21 17:24 by ѧԱ8dgXkO
[¿¼ÑÐ] 0805²ÄÁÏ320Çóµ÷¼Á +3 ÉÎïÓï 2026-03-20 3/150 2026-03-21 15:46 by Î޼ʵIJÝÔ­
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û